|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/397 | (2006.01) |
| A61P 21/00 | (2006.01) |
| (11) | Number of the document | 2307007 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09780938.8 |
| Date of filing the European patent application | 2009-07-22 | |
| (97) | Date of publication of the European application | 2011-04-13 |
| (45) | Date of publication and mention of the grant of the patent | 2014-08-27 |
| (46) | Date of publication of the claims translation | 2014-12-29 |
| (86) | Number | PCT/EP2009/059440 |
| Date | 2009-07-22 |
| (87) | Number | WO 2010/010127 |
| Date | 2010-01-28 |
| (30) | Number | Date | Country code |
| 08161005 | 2008-07-23 | EP |
| (72) |
AHMED, Syed Sohail, IT
LONDEI, Marco, US
WRIGHT, Timothy, US
GERGELY, Peter, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Sfingozino-1 fosfato receptorių moduliatoriai ir jų panaudojimas raumenų uždegimo gydymui |
| SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS AND THEIR USE TO TREAT MUSCLE INFLAMMATION |
| Payment date | Validity (years) | Amount | |
| 2016-06-27 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2017-07-22 |